Article Information
PubMed
Published By
History
- Received October 28, 2015
- Revision received December 21, 2015
- Accepted January 14, 2016
- Published online February 4, 2016.
Copyright & Usage
Copyright © 2016 Karve et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Ila P. Karve1,
- Moses Zhang1,
- Mark Habgood1,
- Tony Frugier1,
- Kate M. Brody1,
- Maithili Sashindranath2,
- C. Joakim Ek1,
- Stephane Chappaz3,
- Ben T. Kile3,
- David Wright4,
- Hong Wang4,
- Leigh Johnston4,
- Maria Daglas2,
- Robert C. Ates1,
- Robert L. Medcalf2,
- Juliet M. Taylor1 and
- Peter J. Crack1
- 1Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, Victoria, Australia, 3010
- 2Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia, 3004
- 3ACRF Chemical Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia 3052
- 4Florey Imaging, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia 3052
- Correspondence should be addressed to Peter Crack, Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, Victoria 3010, Australia. E-mail: pcrack{at}unimelb.edu.au.
Author contributions
↵2 Author contributions: I.P.K., M.Z., T.F., K.M.B., S.C., D.W., H.W., and P.J.C. performed research; I.P.K., T.F., M.S., C.J.E., S.C., D.W., M.D., J.M.T., and P.J.C. analyzed data; M.H., T.F., M.S., C.J.E., B.T.K., and P.J.C. contributed unpublished reagents/analytic tools; L.J., R.C.A., R.L.M., J.M.T., and P.J.C. designed research; I.P.K., J.M.T., and P.J.C. wrote the paper.
Disclosures
Funding
Department of Health, Australian Government | National Health and Medical Research Council (NHMRC)
501100000925; APP1044714Australian Research Council
Other Version
- You are viewing the most recent version of this article.
- previous version (February 04, 2016).
Article usage
In this issue
Ablation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain Injury
